0001437749-22-013131.txt : 20220519
0001437749-22-013131.hdr.sgml : 20220519
20220519204243
ACCESSION NUMBER: 0001437749-22-013131
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220517
FILED AS OF DATE: 20220519
DATE AS OF CHANGE: 20220519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Furcht Leo
CENTRAL INDEX KEY: 0001775749
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38207
FILM NUMBER: 22945011
MAIL ADDRESS:
STREET 1: C/O CELCUITY, 16305 36TH AVENUE N.
STREET 2: #100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55445
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celcuity Inc.
CENTRAL INDEX KEY: 0001603454
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
BUSINESS PHONE: 763-392-0767
MAIL ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
FORMER COMPANY:
FORMER CONFORMED NAME: Celcuity LLC
DATE OF NAME CHANGE: 20140324
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-05-17
0001603454
Celcuity Inc.
CELC
0001775749
Furcht Leo
16305 36TH AVENUE NORTH
SUITE 100
MINNEAPOLIS
MN
55446
1
Stock Option (right to buy)
1.6000
2022-12-14
Common Stock
250
250
D
Stock Option (right to buy)
1.6000
2023-12-14
Common Stock
250
250
D
Stock Option (right to buy)
3.6000
2024-12-14
Common Stock
250
250
D
Stock Option (right to buy)
7.6000
2025-12-14
Common Stock
250
250
D
Stock Option (right to buy)
7.6000
2026-12-14
Common Stock
250
250
D
Stock Option (right to buy)
18.95
2022-05-17
4
D
0
500
D
2027-12-29
Common Stock
500
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
500
A
2027-12-29
Common Stock
500
500
D
Stock Option (right to buy)
23.99
2022-05-17
4
D
0
500
D
2028-12-31
Common Stock
500
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
500
A
2028-12-31
Common Stock
500
500
D
Stock Option (right to buy)
22.45
2022-05-17
4
D
0
5054
D
2029-05-16
Common Stock
5054
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
5054
A
2029-05-16
Common Stock
5054
5054
D
Stock Option (right to buy)
5.1000
2030-05-14
Common Stock
25308
25308
D
Stock Option (right to buy)
26.99
2022-05-17
4
D
0
4619
D
2031-05-12
Common Stock
4619
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
4619
A
2031-05-12
Common Stock
4619
4619
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
24449
0
A
2032-05-17
Common Stock
24449
24449
D
Fully vested.
The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option.
This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders.
/s/ Eric O. Madson as Attorney-in-Fact for Leo Furcht pursuant to Power of Attorney previously filed.
2022-05-19